他们意识到很多MRP里逐行逐项的制程时间并不与真实生产状况是同步的。
They realized that many of the lead-times in the MRP where out of synch with the reality of production and went into it line by line, item by item.
诺蒂对此的解释是,他们不可能通过逐项稽核的方式来评审,否则评审工作早已“死亡”。 他还说评判的依据是基于书本身的价值,而非名声。
But Naughtie said it would have been "death" to judge by box-ticking and they had had to decide on the individual merit of the books, not reputations.
这需要采取一种谨慎的逐项方法来处理每个产品或过程发放之后的生物安全的法律问题。
This calls for a cautious case-by-case approach to address legitimate concerns for the biosafety of each product or process prior to its release.
应用推荐